CVS chooses Amgen's new cholesterol drug over competitor
November 23, 2015 at 08:00 AM EST
NEW YORK, Nov 23 (Reuters) - U.S. drug benefit manager CVS Health said on Monday that it would add Amgen Inc.'s Repatha cholesterol treatment to its list of covered drugs for private plans over a competing treatment from Sanofi SA and Regeneron Pharmaceuticals.